CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
April 29th 2025
A chance meeting with my childhood friend reminded me — and others— that living with cancer means taking things one day at a time.
Firstline Kadcyla Results Disappointing in HER2-Positive Metastatic Breast Cancer Trial
December 19th 2014Two HER2-targeting regimens anchored by Kadcyla (T-DM1) failed to outperform the standard strategy of Herceptin plus chemotherapy in women newly diagnosed with advanced HER2-positive breast cancer.
Subtype of Triple-Negative Breast Cancer Responds to Neoadjuvant Avastin
December 18th 2014The addition of Avastin (bevacizumab) to standard neoadjuvant chemotherapy significantly improved pathologic complete response rates in women with basal-like breast cancer compared with non-basal-like subtypes.
Upfront Faslodex Improves Survival Over Anastrozole in Estrogen-Positive Metastatic Breast Cancer
December 17th 2014Faslodex (fulvestrant) improved overall survival by nearly six months compared with anastrozole as initial hormone therapy for postmenopausal women with estrogen receptor-positive advanced breast cancer, according to findings from the phase 2 FIRST trial.
Keytruda Produces Antitumor Responses in Triple-Negative Breast Cancer
December 12th 2014The PD-1 inhibitor Keytruda (pembrolizumab) has demonstrated promising clinical activity with an acceptable safety profile in heavily pretreated patients with recurrent metastatic triple-negative breast cancer (TNBC).
Abraxane Wins Neoadjuvant Taxane Battle in Breast Cancer Trial
December 11th 2014Abraxane (nab-paclitaxel) proved markedly more effective than conventional paclitaxel as part of a neoadjuvant regimen for patients with high-risk, early breast cancer, according to results presented at the 2014 San Antonio Breast Cancer Symposium.